Cognition Disorders Clinical Trial
— SISOfficial title:
Southend Imaging Study
NCT number | NCT02736396 |
Other study ID # | P0867 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 2016 |
Est. completion date | September 2020 |
Verified date | December 2020 |
Source | Mid and South Essex NHS Foundation Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The study objective is to correlate global cognition and episodic memory performance to resting state fMRI functional connectivity. This is a non-treatment, prospective, natural history data collection study in a cross-sectional cohort of patients with cognitive impairment.
Status | Completed |
Enrollment | 37 |
Est. completion date | September 2020 |
Est. primary completion date | November 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility | Inclusion Criteria: - Informed consent - Cognitive impairment - Age from 18 to 100 years - On stable medication for 1 month before the screening visit; on or off cholinesterase inhibitors - Fluency in English and adequate premorbid intellectual functioning Exclusion Criteria: - Any contraindication to MRI scanning - Clinically significant psychiatric disorder (e.g. depression) - Current clinically significant illness that could confound the results of the study - History of alcohol or drug dependence or abuse - Current use of anticonvulsant or narcotic medications. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Southend Hospital | Westcliff on Sea | Essex |
Lead Sponsor | Collaborator |
---|---|
Mid and South Essex NHS Foundation Trust | Anglia Ruskin University |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of the functional connectivity in the Default Mode Network . | Evaluating the correlation of the Default Mode Network functional connectivity to types of dementia. | 4 years | |
Secondary | Correlation of cognitive performance to functional connectivity. | To evaluate the correlation between individual measures of functional connectivity and global and episodic cognitive performance as measured by neuropsychological tests. | 4 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02488720 -
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
|
||
Recruiting |
NCT03544801 -
Renji Cerebral Small Vessel Disease Corhort Study
|
||
Recruiting |
NCT02813434 -
Cerebral Amyloid Imaging Using Florbetapir (AV-45)
|
Phase 3 | |
Completed |
NCT00400790 -
Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane
|
N/A | |
Completed |
NCT00052091 -
Therapy for Depressed Elders With Thought Problems
|
Phase 3 | |
Completed |
NCT00021866 -
Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy
|
N/A | |
Completed |
NCT00267163 -
Brain Imaging and Mental Disorders of Aging Intervention
|
Phase 4 | |
Not yet recruiting |
NCT04079075 -
Multiple Interventions to Prevent Cognitive Decline
|
N/A | |
Terminated |
NCT03696082 -
A Precision Rehabilitation Approach to Counteract Age-Related Cognitive Declines
|
N/A | |
Completed |
NCT02918539 -
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
|
||
Active, not recruiting |
NCT01708837 -
Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction
|
Phase 4 | |
Completed |
NCT01290939 -
Bevacizumab and Lomustine for Recurrent GBM
|
Phase 3 | |
Terminated |
NCT00548327 -
The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
|
Phase 2 | |
Unknown status |
NCT00256425 -
Cognitive Rehabilitation of Glioma Patients
|
Phase 3 | |
Recruiting |
NCT03926351 -
High Dose Omega 3 in People at Risk for Dementia
|
Phase 2 | |
Completed |
NCT02118571 -
Schizophrenia Cognition Scale Development
|
N/A | |
Completed |
NCT01481961 -
Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease
|
N/A | |
Completed |
NCT00788918 -
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
|
N/A | |
Completed |
NCT00564902 -
The Zeaxanthin and Visual Function Study
|
N/A | |
Completed |
NCT00529581 -
A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
|
Phase 2 |